Baloglu Esra, Ay Senyıgıt Zeynep, Karavana Sinem Yaprak, Vetter Anja, Metın Dilek Yesim, Hilmioglu Polat Suleyha, Guneri Tamer, Bernkop-Schnurch Andreas
Department of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Turkey.
Chem Pharm Bull (Tokyo). 2011;59(8):952-8. doi: 10.1248/cpb.59.952.
The main objective of this work was to develop antifungal matrix tablet for vaginal applications using mucoadhesive thiolated polymer. Econazole nitrate (EN) and miconazole nitrate (MN) were used as antifungal drugs to prepare the vaginal tablet formulations. Thiolated poly(acrylic acid)-cysteine (PAA-Cys) conjugate was synthesized by the covalent attachment of L-cysteine to PAA with the formation of amide bonds between the primary amino group of L-cysteine and the carboxylic acid group of the polymer. Vaginal mucoadhesive matrix tablets were prepared by direct compression technique. The investigation focused on the influence of modified polymer on water uptake behavior, mucoadhesive property and release rate of drug. Thiolated polymer increased the water uptake ratio and mucoadhesive property of the formulations. A new simple dissolution technique was developed to simulate the vaginal environment for the evaluation of release behavior of vaginal tablets. In this technique, daily production amount and rate of the vaginal fluid was used without any rotational movement. The drug release was found to be slower from PAA-Cys compared to that from PAA formulations. The similarity study results confirmed that the difference in particle size of EN and MN did not affect their release profile. The release process was described by plotting the fraction released drug versus time and n fitting data to the simple exponential model: M(t)/M(∞)=kt(n). The release kinetics were determined as Super Case II for all the formulations prepared with PAA or PAA-Cys. According to these results the mucoadhesive vaginal tablet formulations prepared with PAA-Cys represent good example for delivery systems which prolong the residence time of drugs at the vaginal mucosal surface.
这项工作的主要目的是使用粘膜粘附性硫醇化聚合物开发用于阴道给药的抗真菌基质片剂。硝酸益康唑(EN)和硝酸咪康唑(MN)用作抗真菌药物来制备阴道片剂制剂。硫醇化聚丙烯酸-半胱氨酸(PAA-Cys)共轭物是通过将L-半胱氨酸共价连接到PAA上,使L-半胱氨酸的伯氨基与聚合物的羧酸基团之间形成酰胺键而合成的。阴道粘膜粘附基质片剂采用直接压片技术制备。研究重点在于改性聚合物对水吸收行为、粘膜粘附性和药物释放速率的影响。硫醇化聚合物提高了制剂的水吸收比率和粘膜粘附性。开发了一种新的简单溶出技术来模拟阴道环境,以评估阴道片剂的释放行为。在该技术中,使用了每日阴道液的产生量和速率,且无任何旋转运动。发现与PAA制剂相比,PAA-Cys制剂的药物释放较慢。相似性研究结果证实,EN和MN粒径的差异不影响其释放曲线。通过绘制释放药物分数与时间的关系图并将数据拟合到简单指数模型:M(t)/M(∞)=kt(n)来描述释放过程。所有用PAA或PAA-Cys制备的制剂的释放动力学均确定为超级Ⅱ型。根据这些结果,用PAA-Cys制备的粘膜粘附性阴道片剂制剂是延长药物在阴道粘膜表面停留时间的给药系统的良好范例。